Daily News Podcast

FDA approval for 2 HIV drugs


 

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections. Subscribe to the MDedge Daily News wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Sleepio app tied to reducing insomnia, depression
MDedge Neurology
5 digital HIPAA myths
MDedge Neurology
Screen for cervical cancer based on age, risk
MDedge Neurology
Is it time for PCPs to take over chronic HCV?
MDedge Neurology
Rivaroxaban data abound at ESC 2018
MDedge Neurology
New MI definition for infarction vs injury
MDedge Neurology
Lorcaserin shows cardiovascular safety
MDedge Neurology
Lung function decline linked to cardiovascular risk
MDedge Neurology
Rivaroxaban beats aspirin for VTE
MDedge Neurology
New and Noteworthy Information—September 2018
MDedge Neurology